Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nausea × ramosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 2 Postoperative Nausea and Vomiting 1 Pain, Postoperative 1 Neoplasms 1 Nausea 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Agnosia 1

Interventions

Aprepitant 11 Palonosetron 8 Dexamethasone 7 Ondansetron 5 Olanzapine 5 netupitant 2 Fluorouracil 2 Calcium Dobesilate 2 yangzheng xiaoji 1 rolapitant 1 ramosetron 1 niraparib 1 netupitant, palosentron drug combination 1 nabiximols 1 isatuximab 1 ginger extract 1 fosaprepitant 1 dolasetron 1 casopitant 1 Tropisetron 1 Therapeutics 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 Oxaliplatin 1 Octreotide 1 Midazolam 1 Leucovorin 1 Lactose 1 L 758298 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡